Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 515,938 shares at $38.81 ($20.0M) on 2025-10-20, disclosed to the SEC on 2025-10-22.
Scheduled sale ($20.0M) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.81 | 98,934 | $3.8M | 19.2% |
| 2 | $38.81 | 98,934 | $3.8M | 19.2% |
| 3 | $39.32 | 22,314 | $877K | 4.4% |
| 4 | $39.32 | 22,314 | $877K | 4.4% |
| 5 | $38.77 | 39,331 | $1.5M | 7.6% |
| 6 | $38.77 | 39,331 |
| $1.5M |
| 7.6% |
| 7 | $38.83 | 97,390 | $3.8M | 18.9% |
| 8 | $38.83 | 97,390 | $3.8M | 18.9% |
| Total | $38.86 avg | 515,938 | $20.0M | 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |
| KNSA | SELL | 2025-05-22 | $127K | — | Filing → |